Le Lézard
Classified in: Covid-19 virus

Global Starch Sweetener Market Growth, Trends, and Forecast 2020-2025 with COVID-19 Impact Assessment - ResearchAndMarkets.com


The "Global Starch Sweetener Market - Growth, Trends, and Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.

Global Starch Sweetener Market is projected to grow at a CAGR of 4.55% during the forecast period 2020-2025.

The inclination toward low-calorie sweetener and low-calorie beverages, such as diet coke and low-calorie drinks, and low-calorie foods, such as yogurt, ice cream, and grain-based desserts, has gained popularity worldwide. The physiology of sweetness receptors is also being studied in greater detail, and to the depths that is unprecedented, with an endeavor to make food and beverages sweet without using sugar.

Currently, the consumption of sugar substitutes, such as xylitol, erythritol, and mannitol, is increasing rapidly across the world. This is attributed to consumer awareness, government regulations to reduce sugar consumption, and application in many health and wellness food products in the market.

Key Market Trends

Increasing Investments in the Starch Market to Strengthen the Starch Sweeteners Production

Wheat is the primary feedstock for starch production followed by corn and potato. Specialties like green pea, rice, or chickpea are still minimal and only account for less than 0.5% in the European market. More importantly, the increasing number of starch manufacturers are investing in the starch and sweeteners market in Europe to support the local economy and local community while positioning the business for long term growth.

Glucose syrups are used in confectionery mainly for their anti-crystallizing role, while in brewing, they are especially used to impart sweetness to the final product. Glucose syrups can adapt, as with the starch from which they result, into a considerable variety of products, each developing specific properties. Moreover, Germany-based manufacturer, Jacking Group, also announced its plans to build a new wheat starch facility at the existing plant in Hamm. The new facility is expected to increase the wheat processing capacity and double starch output, thus, creating a potential market for starch-based sweeteners in the near future.

North America holds a Prominent Share

The demand for sugar substitutes in the North American region is expected to be fueled by the increasing concerns regarding the health impact of excess sugar consumption and increased application of low Glycemic Index (GI) sugar substitutes in processed food and beverages. By using different blends of low-calorie sweeteners, subtle taste options can be achieved. Moreover, there has been growing demand for sweeteners, such as High Fructose Corn Syrup x (HFCS) in confectionery and bakery applications, which is creating a huge market for the sweeteners in the country. In the United States, glucose-fructose syrup also referred to as HFCS, generally comes in two varieties, with a 55% fructose content (HFCS 55) and a 42% glucose-fructose syrup (HFCS 42), which in turn boosting the starch sweetener market in the region.

Competitive Landscape

The major global players have a broad range of products and a strong geographical presence. These factors give them a competitive advantage in the market. These companies are focused on innovative product launches, as they are trying to cater to various preferences of the consumers, globally. In order to sustain in the competitive market, the companies are enhancing their product portfolios constantly and strategically tapping into the possibilities of the new markets and segments.

Key players in the market are Cargill, Tate & Lyle PLC, Tereos SA, Ingredion, and DuPont Danisco.

Key Topics Covered:

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Drivers

4.2 Market Restraints

4.3 Porters Five Forces Analysis

5 MARKET SEGMENTATION

5.1 By Product Type

5.1.1 Dextrin

5.1.2 Fructose

5.1.3 High-fructose Corn Syrup

5.1.4 Glucose Syrups

5.1.5 Sugar Alcohols

5.1.5.1 Sorbitol

5.1.5.2 Maltitol

5.1.5.3 Xylitol

5.1.5.4 Erythritol

5.1.5.5 Other Sugar Alcohols

5.2 By Application

5.2.1 Bakery

5.2.2 Dairy and Desserts

5.2.3 Beverages

5.2.4 Meat and Meat Products

5.2.5 Soups, Sauces, and Dressings

5.2.6 Confectionery

5.2.7 Dietary Supplements

5.2.8 Other Applications

5.3 Geography

6 COMPETITIVE LANDSCAPE

6.1 Strategies Adopted by Leading Players

6.2 Most Active Companies

6.3 Market Share Analysis

6.4 Company Profiles

6.4.1 Cargill Incorporated

6.4.2 The Archer Daniels Midland Company

6.4.3 Uniglad Ingredients UK Ltd

6.4.4 Tereos SA

6.4.5 Ingredion Inc.

6.4.6 Tate & Lyle PLC

6.4.7 E. I. du Pont de Nemours and Company

6.4.8 VOGELBUSCH Biocommodities GmbH

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

8 AN ASSESSMENT OF THE IMPACT OF COVID-19 ON THE INDUSTRY

For more information about this report visit https://www.researchandmarkets.com/r/ro72co


These press releases may also interest you

at 08:30
According to a new report published by Dialogue Health Technologies Inc., Canada's leading health and wellness virtual care platform, Canadians' overall well-being is at a low point as they struggle with lifestyle challenges around sleep and physical...

at 08:30
Applied Biological Laboratories Inc, the biotechnology company behind the innovative new cold and flu remedy Biovanta and other scientifically validated natural products, has named Rob Keen its new CEO, effective April 24. "I am...

at 08:30
Zoomd Technologies Ltd.  and its wholly-owned subsidiary Zoomd Ltd. (collectively, "Zoomd" or the "Company"), the marketing technology (MarTech) user-acquisition and engagement platform, today reported its financial results for the three months and...

at 08:00
Catheter Precision, Inc. ($VTAK), a leading MedTech company specializing in innovative products for cardiac electrophysiology, including its VIVO™ and LockeT products, announces that is has received its first purchase order (PO) for LockeT...

at 07:35
Arrowhead Pharmaceuticals, Inc. announced today that it has dosed the first subjects in a Phase 1/2a clinical trial (NCT06209177) of ARO-CFB, the company's investigational RNA interference (RNAi) therapeutic, in up to 66 healthy volunteers and...

at 07:35
Fortive Corporation ("Fortive") today announced financial results for the first quarter of 2024. For the first quarter, net earnings were $207 million. For the same period, adjusted net earnings were $295 million, which excludes the $63 million...



News published on and distributed by: